A model for the interim analysis process:-Reference-Cited by-同舟云学术

A model for the interim analysis process:

Published:2003-02 Issue:1 Volume:24 Page:51-65
ISSN:0197-2456
Container-title:Controlled Clinical Trials
language:en
Short-container-title:Controlled Clinical Trials

Author:

Delgado-Herrera Leticia,Anbar Dan

Publisher

Elsevier BV

Subject

Pharmacology

Reference10 articles.

1. International Conference on Harmonisation. Guidance on statistical principles for clinical trials; availability. Department of Health and Human Services FDA. Federal Register. September 16, 1998;63(179):49583–49598.

2. Evaluating therapeutic interventions;Fleming;Stat Sci,1992

3. Policies for study monitoring and interim reporting of results;Green;J Clin Oncol,1987

4. Interim analysis in the pharmaceutical industry;Biostatistics;Control Clin Trials,1993

5. Monitoring of clinical trials;Fleming;Control Clin Trials,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Audit of Interim Analyses of Randomized Controlled Trials (RCTs) Published in Three High Impact Factor Medical Journals Over a Seven- year Period (2012-2018);Reviews on Recent Clinical Trials;2021-11

2. Nonsurgical treatment outcomes for surgical candidates with lumbar disc herniation: a comprehensive cohort study;Scientific Reports;2021-02-16

3. Sharing interim trial results by the Data Safety Monitoring Board with those responsible for the trial’s conduct and progress: a narrative review;Trials;2017-03-09

4. Interim Analysis: What Regulatory Affairs Professionals Need to Know;Drug Information Journal;2010-11

5. Regulatory Perspectives on Data Safety Monitoring Boards;Drug Safety;2004